StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

NewcelX's enterprise value was $14.36M on Nov 11, 2026, against $16.35M a year earlier. Over the last 5 years it ranged from $7.59M to $490.94M, with a median of $72.21M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$14.36M+89.3%
2025Dec 31, 2025$7.59M-62.5%
2024Dec 31, 2024$20.25M-90.3%
2023Dec 29, 2023$208.78M-8.5%
2022Dec 30, 2022$228.08M+79.8%
2021Dec 31, 2021$126.87M–

More NewcelX figures

See a number that looks wrong?